Asthma severity and adequacy of management [2] (multiple letters)

Lancet

Volumn 359, Issue 9300, 2002, Pages 75-

  Hart, Simon P ^a   Ebihara, Satoru ^b   Ebihara, Takae ^b   Kanda, Akio ^b   Takahashi, Hidenori ^b   Sasaki, Hidetada ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; METHYLXANTHINE DERIVATIVE; THEOPHYLLINE; BRONCHODILATING AGENT;

ASTHMA; CAROTID BODY; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BIOAVAILABILITY; EMERGENCY WARD; HEALTH CARE COST; HUMAN; LETTER; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; STIMULATION; UNITED KINGDOM; CLASSIFICATION; EMERGENCY; HOSPITALIZATION; JAPAN; NOTE; PRACTICE GUIDELINE;

AMINOPHYLLINE; ASTHMA; BRONCHODILATOR AGENTS; EMERGENCIES; HUMANS; JAPAN; SEVERITY OF ILLNESS INDEX; THEOPHYLLINE; GREAT BRITAIN; GUIDELINES;

EID: 0037021991     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07289-6     Document Type: Letter

References (0)